- Universal tolerance of nab-paclitaxel for gynecologic malignancies in patients with prior taxane hypersensitivity reactions
-
Maurer K, Michener C, Mahdi H, Rose PG
- KMID: 2413426
- J Gynecol Oncol.
- 2017 Jul;28(4):e38.
- doi: 10.3802/jgo.2017.28.e38
OBJECTIVE: To report on the incidence of nab-paclitaxel hypersensitivity reactions (HSRs) in patients with prior taxane HSR. METHODS: From 2005 to 2015, all patients who received nab-paclitaxel for a gynecologic malignancy... -
- CITED
-
- Close
- SHARE
-
- Close
- Palonosetron versus granisetron in combination with aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with gynecologic cancer
-
Fujiwara S, Terai Y, Tsunetoh S, Sasaki H, Kanemura M, Ohmichi M
- KMID: 2345922
- J Gynecol Oncol.
- 2015 Oct;26(4):311-319.
- doi: 10.3802/jgo.2015.26.4.311
OBJECTIVE: There is no research regarding the appropriate antiemetic agents for female patients, especially those receiving moderately emetogenic chemotherapy (MEC). We evaluated the antiemetic efficacy of a combination of 5-HT3... -
- CITED
-
- Close
- SHARE
-
- Close
- Knowledge and Learning Needs Related to Cancer Treatment in Gynecological Cancer Patients
-
Seo MS, Choi ES
- KMID: 2415779
- J Korean Acad Nurs.
- 2006 Oct;36(6):942-949.
PURPOSE: This study was to investigate the knowledge and learning needs of chemotherapy in gynecological cancer patients. METHOD: The subjects consisted of 103 gynecological cancer patients receiving chemotherapy... -
- CITED
-
- Close
- SHARE
-
- Close
